Skip to main content
. Author manuscript; available in PMC: 2016 Jun 30.
Published in final edited form as: Gastroenterology. 2016 Feb 23;150(7):1561–1567.e1. doi: 10.1053/j.gastro.2016.02.041

Table 3.

Oral Contraceptive Use and Risk of Steroid Prescription

Never Past Current P trend
Cases/person-months 405/268,059 28/20,995 25/14,225
Incident rate/100,000 person-months 15.1 13.3 17.6
Age-adjusted HR (95% CI) 1.00 1.01 (0.69–1.49) 1.18 (0.79–1.76)
MV-adjusted HR (95% CI)a 1.00 0.98 (0.66–1.44) 1.09 (0.73–1.64)
Cumulative duration of use, y

0 ≤1 >1 and ≤3 >3

Cases/person-months 405/268,059 19/12,497 22/13,470 12/9253
Incident rate/100,000 person-months 15.1 17.1 16.3 13.0
Age-adjusted HR (95% CI) 1.00 1.02 (0.64–1.61) 1.18 (0.77–1.82) 1.04 (0.58–1.86) .58
MV-adjusted HR (95% CI)a 1.00 0.99 (0.63–1.58) 1.11 (0.72–1.71) 0.95 (0.53-1.71) .88
Cumulative DDD use

0 ≤300 >300 and ≤900 >900

Cases/person-months 405/268,059 19/10,104 26/13,090 22/14,847
Incident rate/100,000 person-months 15.1 18.8 19.9 14.8
Age-adjusted HR (95% CI) 1.00 1.28 (0.81–2.03) 1.43 (0.96–2.13) 1.18 (0.77–1.83) .09
MV-adjusted HR (95% CI)a 1.00 1.27 (0.80–2.02) 1.33 (0.89–1.99) 1.11 (0.72–1.72) .20
a

Adjusted for age (years), number of encounters, duration of disease (years), and county.